INTERNATIONAL PATENT: THRYV THERAPEUTICS INC. FILES APPLICATION FOR "SALTS OF 5-CHLORO-2-FLUORO-N-(2-FLUORO-4-(3-METHYL-4-[(1-METHYLPIPERIDIN-4-YL)OXY]-1H-PYRAZOLO[3,4-D]PYRIMIDIN-6-YL)PHENYL)BENZENE SULFONAMIDE AND CRYSTALLINE FORMS THEREOF"

GENEVA, March 8 -- THRYV THERAPEUTICS INC. (1250-999 Boulevard de Maisonneuve OuestMontreal, Quebec H3A 3L4) filed a patent application (PCT/CA2025/051099) for "SALTS OF 5-CHLORO-2-FLUORO-N-(2-FLUORO-4-(3-METHYL-4-[(1-METHYLPIPERIDIN-4-YL)OXY]-1H-PYRAZOLO[3,4-D]PYRIMIDIN-6-YL)PHENYL)BENZENE SULFONAMIDE AND CRYSTALLINE FORMS THEREOF" on Aug 21, 2025. With publication no. WO/2026/044398, the details related to the patent application was published on Mar 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): VIDAL, Marc (1250-999 Boulevard de Maisonneuve OuestMontreal, Quebec H3A 3L4), KHALIFA, Ma...